Terumo Corp. Hits Day Low of JPY 2,473 Amid Price Pressure

Terumo Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 3.16%. The stock reached an intraday low of JPY 2,473.00, reflecting ongoing challenges in its market performance.
Over the past week, Terumo Corp. has seen a decrease of 2.88%, contrasting with a 1.83% increase in the Japan Nikkei 225. The company's performance over the last month shows a modest gain of 1.37%, but this is overshadowed by a significant year-to-date decline of 18.97%. In the longer term, Terumo has faced consistent underperformance, with a three-year decline of 44.51% compared to the benchmark index.

Despite these challenges, Terumo Corp. maintains a strong long-term fundamental strength, evidenced by a healthy EBIT to Interest ratio of 36.60 and a return on capital employed of 11.11%. The company has also demonstrated robust net sales growth at an annual rate of 10.50%. However, its return on equity stands at 9.13%, and the stock trades at a price-to-book ratio of 2.86, indicating a premium valuation relative to its peers.